Form EFFECT Eledon Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 11, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Further Assays Infill Tunkillia Pit Extension Targets
- Department of War Awards Lockheed Martin $58.62B for Multiyear PAC-3 MSE Production to Strengthen the Arsenal of Freedom
- Black Girl Sunscreen Founder Shontay Lundy Inducted into the Sigma Gamma Rho Sorority's 2026 TrailblazerΣ Honorary Membership Class
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
